Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, pain management, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analgesics, orthopedics, hematinic, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business to business in the United States, Europe, Canada, Australia, India, and internationally. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited is a subsidiary of Fosun Pharma Industrial Pte. Ltd.

Dr. C. S. Venkatesan

Senior Vice President of R&D

Mr. Surinder  Koul

Head of Domestic Marketing

Mr. Satnam Singh Loomba

Chief Operating Officer

Ms. Shilpi  Sahay

Deputy General Manager of Human Resources

Dr. Surapanini  Sridevi

Mr. K Raghuramachandra Rao

Head of Quality

Mr. Rong  Wu

Chief Financial Controller

Mr. Srinivas  Sadu

MD, Chief Executive Officer & Executive Director

Mr. Ravi Shekhar Mitra

Chief Financial Officer

Gland Pharma Limited

Gland Pharma Limited 管理结构

管理层信息